NCT06474013: A Clinical Trial to Evaluate the Initial Safety and Efficacy of Repetitive BBB (Blood Brain Barrier) Disruption Using High Intensity Focused Ultrasound 'ExAblate 4000 Type 2.1' in Patients With Alzheimer's Disease
- State
- State not given
- Phase
- No phase
- People
- 15 planned
- Started
- 1 Sep 2024
- Primary completion
- 30 Sep 2024
- Arms
- Blood Brain Barrier (BBB) Disruption
- Results
- None posted
- 25 Jun 2024: Trial registered